Scopus BioPharma Inc. (SCPS)

AI Score

Unlock

0.00

-0.00 (-100.00%)

At close: Mar 24, 2025, 11:51 AM

Scopus BioPharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q2 2018	Q1 2018
Period Ending	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Jun 30, 2018	Mar 31, 2018
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-2.93M	n/a	-1.84M	-1.9M	-3.32M	-4.66M	-6.52M	-2.76M	-15.28M	-3.07M	-714.13K	-875.47K	-7.95M	-619.24K	-963.89K	-797.22K	-437.19K	-491.65K	-152.23K	-122.49K
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-2.93M	-2.68M	-1.84M	-1.9M	-3.32M	-4.66M	-6.52M	-1.4M	-15.63M	-3.41M	-1.05M	-1.16M	-8.03M	-626.14K	-963.89K	-797.22K	-437.19K	-491.65K	-152.23K	-122.49K
Net Income	-2.62M	-2.45M	-1.73M	-1.9M	-3.32M	-4.66M	-6.52M	-1.4M	-15.63M	-3.41M	-1.05M	-1.16M	-8.03M	-626.14K	-963.89K	-797.22K	-437.19K	-491.65K	-152.23K	-122.49K
Selling & General & Admin	935.86K	1.07M	1.09M	981.34K	2.67M	4.29M	6.38M	2.68M	1.73M	1.82M	644.64K	806.04K	710.73K	568.96K	780.32K	715.1K	338.41K	393.01K	119.73K	89.99K
Research & Development	1.99M	1.61M	745.9K	917.27K	649.47K	369.11K	135.79K	77.53K	13.56M	1.25M	69.49K	69.42K	7.23M	50.28K	183.57K	82.12K	98.78K	98.64K	32.5K	32.5K
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	2.93M	2.68M	1.84M	1.9M	3.32M	4.66M	6.52M	2.76M	15.28M	3.07M	714.13K	875.47K	7.95M	619.24K	963.89K	797.22K	437.19K	491.65K	152.23K	122.49K
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	110.67K	332K	332K	336.78K	284.52K	79.94K	6.89K	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	2.93M	2.68M	1.84M	1.9M	3.32M	4.66M	6.52M	2.76M	15.28M	3.07M	714.13K	875.47K	7.95M	619.24K	963.89K	797.22K	437.19K	491.65K	152.23K	122.49K
Income Tax Expense	n/a	n/a	-105.05K	-26.77K	n/a	n/a	680.53M	110.67K	332K	n/a	n/a	n/a	n/a	n/a	1.00	n/a	-478.15K	-532.03K	n/a	n/a
Shares Outstanding (Basic)	39.74M	30.37M	21.09M	21.09M	21.09M	21.09M	17.25M	17.15M	16.19M	15.34M	13.36M	14.98M	14.98M	14.98M	14.98M	14.98M	14.98M	14.98M	14.98M	14.98M
Shares Outstanding (Diluted)	39.74M	30.37M	21.09M	21.09M	21.09M	21.09M	17.25M	17.15M	16.19M	15.34M	13.36M	14.98M	14.98M	14.98M	14.98M	14.98M	14.98M	14.98M	14.98M	14.98M
EPS (Basic)	-0.07	-0.08	-0.08	-0.09	-0.16	-0.22	-0.38	-0.08	-0.97	-0.22	-0.08	-0.08	-0.54	-0.04	-0.06	-0.05	-0.03	-0.03	-0.01	-0.01
EPS (Diluted)	-0.07	-0.08	-0.08	-0.09	-0.16	-0.22	-0.38	-0.08	-0.97	-0.22	-0.08	-0.08	-0.54	-0.04	-0.06	-0.05	-0.03	-0.03	-0.01	-0.01
EBITDA	-2.93M	-2.68M	-1.84M	-1.9M	-3.32M	-4.66M	-6.52M	-1.29M	-15.3M	-3.07M	-713.76K	-875.1K	-7.94M	-618.89K	-963.31K	-797.17K	-437.19K	-491.65K	-152.23K	-122.49K
EBIT	-2.93M	-2.68M	-1.84M	-1.9M	-3.32M	-4.66M	-6.52M	-1.29M	-15.3M	-3.07M	-714.13K	-875.47K	-7.95M	-619.24K	-963.89K	-797.22K	-437.19K	-491.65K	-152.23K	-122.49K
Depreciation & Amortization	334.00	231.00	231.00	306.00	582.00	609.00	353.00	375.00	400.00	372.00	367.00	362.00	355.00	356.00	580.00	46.00	40.96K	40.37K	n/a	n/a